Stockscreener 앱 받기
22.85
1.78%
0.40
시장 영업 전:
22.75
-0.10
-0.44%
전일 마감가:
$22.45
열려 있는:
$22.98
하루 거래량:
2.10M
Relative Volume:
1.51
시가총액:
$2.02B
수익:
-
순이익/손실:
$-804.34M
주가수익비율:
-2.4283
EPS:
-9.41
순현금흐름:
$-531.06M
1주 성능:
+15.17%
1개월 성능:
-3.51%
6개월 성능:
-55.09%
1년 성능:
-42.73%
1일 변동 폭
$22.50
$24.06
1주일 범위
$19.84
$24.06
52주 변동 폭
$15.79
$55.70
바이오헤이븐 Stock (BHVN) Company Profile
명칭
Biohaven Ltd
전화
203-404-0410
주소
215 CHURCH STREET, NEW HAVEN, CT
BHVN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BHVN
Biohaven Ltd
|
22.85 | 2.02B | 0 | -804.34M | -531.06M | -9.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
501.15 | 126.96B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.61 | 65.06B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
649.67 | 37.54B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
259.39 | 32.56B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
255.77 | 26.40B | 3.81B | -644.79M | -669.77M | -6.24 |
바이오헤이븐 Stock (BHVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-09-16 | 개시 | Jefferies | Buy |
| 2024-09-04 | 개시 | Bernstein | Outperform |
| 2024-07-24 | 개시 | Morgan Stanley | Overweight |
| 2024-02-16 | 개시 | RBC Capital Mkts | Outperform |
| 2024-02-06 | 개시 | UBS | Buy |
| 2023-12-22 | 개시 | H.C. Wainwright | Buy |
| 2023-12-08 | 개시 | Robert W. Baird | Outperform |
| 2023-01-24 | 개시 | SVB Securities | Outperform |
| 2023-01-04 | 개시 | JP Morgan | Overweight |
| 2022-12-02 | 개시 | BTIG Research | Buy |
| 2022-10-26 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2022-10-12 | 개시 | Piper Sandler | Overweight |
| 2022-08-19 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-08-08 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2022-05-11 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-19 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-08-10 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-08-03 | 재확인 | Canaccord Genuity | Buy |
| 2021-03-11 | 개시 | UBS | Buy |
| 2020-12-15 | 개시 | H.C. Wainwright | Buy |
| 2020-04-17 | 개시 | Cowen | Outperform |
| 2020-02-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-02-06 | 개시 | Mizuho | Buy |
| 2019-11-22 | 개시 | Wedbush | Outperform |
| 2019-06-25 | 재확인 | Canaccord Genuity | Buy |
| 2019-05-06 | 개시 | Goldman | Buy |
| 2019-04-09 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-03-04 | 재확인 | Needham | Buy |
| 2018-07-03 | 재확인 | Needham | Buy |
| 2018-07-02 | 재확인 | Needham | Buy |
| 2018-04-05 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2018-02-22 | 재확인 | Canaccord Genuity | Buy |
| 2017-12-15 | 개시 | Canaccord Genuity | Buy |
| 2017-10-03 | 재확인 | Needham | Buy |
모두보기
바이오헤이븐 주식(BHVN)의 최신 뉴스
Biohaven Is Now A Compelling Contrarian Play Before Troriluzole's FDA Verdict (NYSE:BHVN) - Seeking Alpha
Raymond James Financial Inc. Buys Shares of 37,033 Biohaven Ltd. (NYSE:BHVN) - Defense World
Finance Watch: Biohaven Gains Up To $600m In Fresh Capital - insights.citeline.com
An Intrinsic Calculation For Biohaven Ltd. (NYSE:BHVN) Suggests It's 47% Undervalued - simplywall.st
19,352 Shares in Biohaven Ltd. (NYSE:BHVN) Acquired by Renaissance Technologies LLC - Defense World
Oberland Capital’s $600 Million Investment in Biohaven - Global Legal Chronicle
Biohaven Ltd [BHVN] Director makes an insider purchase of 32,700 shares worth 1.0 million. - knoxdaily.com
Biohaven (BHVN) Projected to Post Earnings on Thursday - Defense World
Biohaven Ltd. (NYSE:BHVN) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Where are the Opportunities in (BHVN) - news.stocktradersdaily.com
Invesco Ltd. Raises Stock Position in Biohaven Ltd. (NYSE:BHVN) - Defense World
Biohaven Ltd.’s Strategic Expansion and Financial Strength Bolster Buy Rating - TipRanks
Are Smart Investors Making the Right Decision? Biohaven Ltd (BHVN) - Sete News
BHVN’s Market Whiplash: -41.79% YTD Decline, -23.42% Plunge in 30 Days - investchronicle.com
Biohaven secures $600m financing as it awaits FDA prodrug decision - Yahoo
Biohaven (NYSE:BHVN) Given New $57.00 Price Target at Robert W. Baird - Defense World
Biohaven (BHVN) Secures Up to $600M Investment from Oberland Cap - GuruFocus
Biohaven secures up to $600 million from Oberland Capital By Investing.com - Investing.com Nigeria
Biohaven secures up to $600 million from Oberland Capital - Investing.com Australia
BHVN’s price-to-cash ratio: Is it a good investment at the moment? - uspostnews.com
Why BioHaven Stock Is Soaring Today - Mitrade
A Guide To The Risks Of Investing In Biohaven Ltd (BHVN) - knoxdaily.com
Biohaven Ltd. Receives Buy Rating Amid Strategic EU Resubmission and Positive FDA Outlook - TipRanks
Biohaven Rallies On Heels Of $600M Funding Agreement With Oberland - Benzinga
Biohaven to receive investment of up to $600M by Oberland Capital - TipRanks
Biohaven announces investment of up to $600M - Hartford Business Journal
Financial Analysis: Biohaven Ltd (BHVN)’s Ratios Unveil Key Insights - DWinneX
Biohaven Announces Investment by Oberland Capital - Contract Pharma
Stride To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Biohaven Ltd. Secures $600M Investment from Oberland Capital - TipRanks
Biohaven Announces Investment Up To $600 Mln By Oberland Capital - marketscreener.com
Why Biohaven Ltd. Shares Are Tumbling - TipRanks
Biohaven Lands Major $600 Million Deal With Oberland Capital - Finimize
Biohaven Signs Deal for Investment of up to $600 Million by Oberland; Shares up Pre-Bell - marketscreener.com
Biohaven (BHVN) Price Target Cut by Baird Amid Regulatory Develo - GuruFocus
Biohaven Pharma (BHVN) Announces Investment up to $600 Million by Oberland Capital - StreetInsider
Biohaven Lands Massive $600M Backing to Advance First-Ever Treatment for Rare Genetic Disease - Stock Titan
Biohaven Announces Investment up to $600 Million by Oberland Capital - The Malaysian Reserve
Biohaven (NYSE:BHVN) Upgraded at William Blair - Defense World
Biohaven (BHVN) Faces Market Setback After EMA Withdrawal - GuruFocus
Wells Fargo & Company MN Increases Stock Position in Biohaven Ltd. (NYSE:BHVN) - Defense World
Biohaven share price undervaluing pipeline potential, says RBC Capital - Yahoo Finance
Why Biohaven Stock Plummeted by More Than 15% Today - Yahoo Finance
Biohaven stock slides on withdrawal of European marketing application - BioPharma Dive
Biohaven (BHVN) Withdraws EMA Application, U.S. Approval Crucial - GuruFocus
Biohaven (BHVN) Withdraws Troriluzole Application in Europe, Foc - GuruFocus
Biohaven (BHVN) Stock Drops After Withdrawal of EU Drug Applicat - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
Biohaven Ltd. Stock Faces Turbulence Amid Strategic Shifts - TipRanks
Biohaven Ltd (NYSE:BHVN) Shares Surged 25.27% In A Week – But Will They Keep Going Up? - Marketing Sentinel
Biohaven Pharma stock tumbles after withdrawal of Dazluma application in EU By Investing.com - Investing.com South Africa
바이오헤이븐 (BHVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.47%
2.63%
자본화:
|
볼륨(24시간):